Our data unveils a lnc-Helf/PTBP1/PIK3R5/AKT feedforward amplifying signaling to exacerbate the process of hepatic fibrosis and inflammation, thus providing a possible therapeutic strategy for hepatic fibrosis (Additional file 1: Fig. S12). The gene discussed is AKT1; the disease is Hepatic fibrosis.